SCHEMBL18947316

SCHEMBL18947316

C/C=C\CCC(=O)NCCNC(=O)OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.57
▸ LMNA P02545 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ TGM2 P21980 1/20 0.51
▸ L3MBTL1 Q9Y468 4/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ HDAC3 O15379 1/20 0.50
▸ HDAC4 P56524 1/20 0.50
▸ HDAC1 Q13547 1/20 0.50
▸ HDAC7 Q8WUI4 1/20 0.50
▸ HDAC2 Q92769 1/20 0.50
▸ HDAC10 Q969S8 1/20 0.50
▸ HDAC11 Q96DB2 1/20 0.50
▸ HDAC8 Q9BY41 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50
▸ HDAC9 Q9UKV0 1/20 0.50
▸ HDAC5 Q9UQL6 1/20 0.50
▸ NCOR2 Q9Y618 1/20 0.50
▸ MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16553601 0.89 HTT (0.62) HTTLMNASMN1; SMN2TGM2L3MBTL1
SCHEMBL3656920 0.86 HTT (0.68) HTTLMNASMN1; SMN2TGM2L3MBTL1
SCHEMBL30869144 0.83 HTT (0.58) HTTLMNASMN1; SMN2TGM2L3MBTL1
SCHEMBL19384905 0.82 HTT (0.64) HTTLMNASMN1; SMN2TGM2L3MBTL1
SCHEMBL13055383 0.81 LMNA (0.80) HTTLMNASMN1; SMN2TGM2L3MBTL1
SCHEMBL22214968 0.81 HTT (0.63) HTTLMNASMN1; SMN2TGM2L3MBTL1
SCHEMBL12409525 0.81 HTT (0.62) HTTLMNASMN1; SMN2TGM2L3MBTL1
SCHEMBL12712296 0.81 TGM2 (0.63) HTTLMNASMN1; SMN2TGM2L3MBTL1
SCHEMBL11048765 0.79 LMNA (0.63) HTTLMNASMN1; SMN2TGM2L3MBTL1
SCHEMBL7514786 0.79 HTT (0.73) HTTLMNASMN1; SMN2TGM2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3036236-B1 NOVEL NEUROKININ 1 RECEPTOR ANTAGONIST COMPOUNDS II LEO PHARMA AS (DK) 2017-06-07 — — EP disclosed
Send feedback